Prophylaxis of cancer-associated venous thromboembolism with low-molecular-weight heparin-tinzaparin: Real world evidence

Thromboprophylaxis, as a preventive measure for cancer-associated thrombosis (CAT), may be beneficial for patients with active cancer and high-risk for thrombosis. The present post hoc analysis include a total of 407 patients enrolled in the Greek Management of Thrombosis study, who received thrombo...

Descripción completa

Detalles Bibliográficos
Autores principales: Christopoulou, Athina, Ardavanis, Alexandros, Papandreou, Christos, Koumakis, Georgios, Papatsimpas, Georgios, Papakotoulas, Pavlos, Tsoukalas, Nikolaos, Andreadis, Charalambos, Samelis, Georgios, Papakostas, Pavlos, Aravantinos, Gerasimos, Ziras, Nikolaos, Souggleri, Maria, Kalofonos, Charalambos, Samantas, Epameinondas, Makrantonakis, Paris, Pentheroudakis, Georgios, Athanasiadis, Athanasios, Stergiou, Helen, Bokas, Alexandros, Grivas, Anastasios, Tripodaki, Elli-Sofia, Varthalitis, Ioannis, Timotheadou, Eleni, Boukovinas, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850961/
https://www.ncbi.nlm.nih.gov/pubmed/35251346
http://dx.doi.org/10.3892/ol.2022.13235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850961/
https://www.ncbi.nlm.nih.gov/pubmed/35251346
http://dx.doi.org/10.3892/ol.2022.13235

Ejemplares similares